Long-term oxygen therapy remains one of only three interventions — alongside smoking cessation and, in selected patients, pulmonary rehabilitation or lung volume reduction — that extends survival in COPD. The evidence anchoring this is four decades old, the thresholds have not moved materially, and yet in Indian practice, LTOT prescription is persistently miscalibrated. Patients who